Maternal obesity prior to pregnancy associated with birth defects

Mothers of babies born with some structural birth defects—including missing limbs, malformed hearts and underdeveloped spinal cords—appear more likely to be obese prior to becoming pregnant than mothers whose children are born without such defects, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

Overweight and obese women are known to be at risk for chronic diseases, infertility, irregular menstruation and complications during pregnancy, according to background information in the article. In 2003 and 2004, about 51 percent of women aged 20 to 39 were classified as overweight or obese.

D. Kim Waller, Ph.D., of the University of Texas, Houston, and colleagues interviewed 10,249 women in eight states whose babies were born with birth defects between 1997 and 2002. The women were contacted between six weeks and 24 months after the baby’s birth and asked for their height and weight before pregnancy, along with other demographic and medical information. These women were compared with 4,065 women who had babies without birth defects during the same time period.

Mothers of babies with the following seven of 16 birth defects were more likely to be obese than mothers of infants without birth defects:

Mothers of babies with gastroschisis, which is similar to omphalocele but involves organs protruding through a defect in the abdominal wall that is not the navel, were significantly less likely to be obese than mothers of babies without birth defects.

“The reasons for an association between maternal obesity and a spectrum of structural birth defects are unknown,” the authors write. “Both animal studies and human studies provide substantial evidence that alterations in glycemic control are responsible for an increased risk of a range of structural birth defects among women who have diabetes prior to becoming pregnant. Thus, a similar mechanism to that occurring in women with diabetes may be responsible for the associations observed between maternal obesity and specific categories of birth defects.” Women with type 2 diabetes were excluded from the study, and when the analysis was performed also excluding women with gestational diabetes, the results were similar. However, undiagnosed cases of type 2 or gestational diabetes may have affected the results.

“Our study supports previous evidence as well as provides new evidence for the associations between maternal obesity and particular categories of birth defects,” the authors conclude. “Future inquiries are needed to unravel the underlying reasons for these associations.”

Source: JAMA and Archives Journals

Related stories:

New blood clot guidelines for pregnant women
Blood clot recommendations highlight challenges for pediatric and pre-surgery populations
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies. Published as a supplement in the June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), Antithrombotic and Thrombolytic Therapy: ACCP Evidence-Based Clinical Practice Guidelines, Eighth Edition was developed by an international panel of 90 experts and includes more than 700 of the most comprehensive recommendations related to the prevention, treatment, and long-term management of thrombotic disorders. The guidelines include chapters on the challenges in preventing and treating thrombosis in pregnant women and children, and on managing peri- and postoperative patients, while also reinforcing previous guidelines related to the routine use of preventive therapies, including aspirin.
Sexually transmitted disease, urinary tract infections may be bad combination for birth defect
Chances of gastroschisis increase fourfold in babies whose moms have both infections
Women who reported having both a sexually transmitted disease (STD) and urinary tract infection (UTI) just before or during early pregnancy were four times more likely to have babies with gastroschisis—a severe birth defect in which infants are born with their intestines and other internal organs outside the abdomen, University of Utah researchers report in the online British Medical Journal.
Abortion drug's off-label use may have led to deaths
Preliminary U-M studies indicate that oral use of RU-486's companion drug misoprostol is safe, but vaginal use may undermine body's immune responses. The off-label use of a drug given with RU-486 to terminate a pregnancy may be responsible for a handful of rare, fatal infections seen in women taking the drugs since 2000, a study by University of Michigan scientists suggests.
Same-day pregnancy test provides valuable guidance to pre-surgery patients
The first trimester of any pregnancy is a precarious time, as about 15 percent of women who know they are pregnant will spontaneously miscarry. This risk increases when pregnant women undergo surgery, which is why Hospital for Special Surgery (HSS) in New York instituted a same-day pregnancy testing protocol. A study published in the April issue of Anesthesia and Analgesia shows that this protocol is effective in identifying unknown pregnancies to the benefit of the patient, the physician and the hospital.
Zebrafish enable scientists to study the migration of neurons that enable sexual maturity
Scientists are watching a small group of neurons that enable sexual maturity and fertility make a critical journey: from where they form, near the developing nose, to deep inside the brain.
Prenatal biochemical screening only detects half of chromosomal abnormalities
Prenatal biochemical screening tests are widely used to look for chromosomal abnormalities in the fetus which can lead to serious handicap, or even death during gestation or in the first few days after birth. But these tests are only able to detect fewer than half of the total chromosomal abnormalities in the fetus, a scientist will tell the annual conference of the European Society of Human Genetics today.
No link between antidepressants and birth defects
Expectant mothers can safely use prescribed antidepressants during their first trimester, according to a new study from the Université de Montréal and Ste. Justine Hospital published in the May edition of the British Journal of Psychiatry.
Study finds diabetes doubling before motherhood
Diabetes before motherhood more than doubled in six years among teenage and adult women, according to a Kaiser Permanente study published in the May issue of Diabetes Care.

News discussion:

Medicine & Health news